...
首页> 外文期刊>Journal of cardiac failure >Sinus Tachycardia During The First Year after Heart Transplantation is Associated with Worse Long-Term Outcomes
【24h】

Sinus Tachycardia During The First Year after Heart Transplantation is Associated with Worse Long-Term Outcomes

机译:心脏移植后的第一年鼻窦心动过速与更糟糕的长期结果相关

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundElevated heart rate (HR) is an important risk factor for adverse outcomes in healthy people and across the entire spectrum of cardiovascular diseases. The effect of an elevated heart rate on patients post heart transplantation (HTx) though has not been well established. ObjectiveThe aim of this study was to assess the predictors and prognostic significance of elevated HR after HTx. MethodsA total cohort of 394 patients who underwent HTx at two academic medical centers between 2005-2016 were divided into two groups based on HR at 1 year after HTx: 1) HR≥95 beats/min (bpm; n=162 [41%]) and 2) HR<95bpm (n=232 [59%]). Median follow-up was 6.6 (25%-75% IQR 2.2 – 7.5) years. ResultsHR≥95?bpm at 1-year post-HTx was associated with younger donor age (OR 1.1; CI 1.0-2.3,P=0.05), whereas HR<95 bpm was associated with heavy alcohol use in the donor (OR 0.43; CI 0.17-0.61;P=.04) and African-American recipients race (OR 0.40; 95% CI 0.19-0.85;P=0.02). Left ventricular diastolic dimension (4.3±0.5cm vs. 4.5±0.5cm, p < 0.001), mass (158±44 mg vs. 189±59 mg, p<0.001) and ejection fraction (56±5.2% vs 59±9.1%, p=0.03) were lower in HR≥95 group at last follow up echo. HR≥95?bpm was associated with the development of cardiac allograft vasculopathy (CAV) [] and increased post-HTx mortality [] and was independent predicter of CAV (HR 2.7, 95% CI 1.4–5.5, p=0.005) and mortality (HR 3.9, 95% CI 1.4-7.7, p=0.02) after Cox proportional hazard analysis. ConclusionHR≥95 is associated with long term decrease in LV mass and systolic function, development of CAV and reduced survival. Studies investigating the effect of medical HR reduction on post-HTx outcomes are warranted.
机译:背景技术心率(HR)是健康人群和整个心血管疾病的不良结果的重要风险因素。心率升高对心脏移植后患者(HTX)的影响虽然尚未得到明确。本研究的目标目的是评估HTX后HR升高的预测因子和预后显着性。 MethaSA在2005 - 2016年两种学术医疗中心接受HTX的394名患者的总群组分为394岁,在HTX:1)HR≥95次(BPM; N = 162 [41%] )和2)HR <95bpm(n = 232 [59%])。中位后续时间为6.6(25%-75%IQR 2.2 - 7.5)年。结果水肿≥95?BPM在1年后HTX与年轻供体年龄(或1.1; CI 1.0-2.3,P = 0.05)相关,而HR <95bpm与供体中的重醇(或0.43; CI 0.17-0.61; p = .04)和非洲裔美国受助人的比赛(或0.40; 95%CI 0.19-0.85; p = 0.02)。左心室舒张尺寸(4.3±0.5cm,4.5±0.5cm,p <0.001),质量(158±44 mg与189±59mg,p <0.001)和射血分数(56±5.2%Vs 59±9.1在最后一次跟进回声时,HR≥95组的%,p = 0.03)较低。 HR≥95?BPM与心脏同种异体移植血管病变(CAV)[]的发展有关,并增加了HTX后死亡率[],并且是SAV的独立预选器(HR 2.7,95%CI 1.4-5.5,P = 0.005)和死亡率(HR 3.9,95%CI 1.4-7.7,P = 0.02)在COX比例危险分析后。结论HR≥95与LV质量和收缩功能的长期减少,CAV的开发和减少存活率相关。有必要研究调查医疗人力资源的效果对HTX后果的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号